TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 06 2025
0mins
Source: PRnewswire
Company Delisting Announcement: TFF Pharmaceuticals, Inc. has notified Nasdaq of its intent to voluntarily delist its common stock in connection with the planned liquidation and dissolution of the company, with the delisting expected to take effect around February 26, 2025.
Forward-Looking Statements Disclaimer: The announcement includes forward-looking statements that are subject to risks and uncertainties, indicating that actual results may differ from those projected, particularly regarding the wind-down process and market conditions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
